Download free PDF

Pediatric Imaging Market Size & Share 2026-2035

Report ID: GMI13381
   |
Published Date: November 2026
 | 
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:

Pediatric Imaging Market Size

The pediatric imaging market, valued at USD 10.06 billion in 2025, is projected to reach USD 10.76 billion in 2026 and expand at a CAGR of 7.2% from 2026 to 2035, attaining USD 20.12 billion by 2035.

Pediatric Imaging Market Key Takeaways

2025 Market Size
$ 10.06 Billion
2026 Market Size
$ 10.76 Billion
2035 Forecast Market Size
$ 20.12 Billion
CAGR (2026–2035)
7.2%
Regional Dominance
Largest Market
North America
Fastest Growing Region
Asia Pacific
Key Players
  • Market Leader: Siemens Healthineers led with over 26.5% market share in 2025.

  • Leading Players: Top 5 players in this market include Siemens Healthineers, GE HealthCare, Koninklijke Philips, Canon Medical Systems, FUJIFILM Healthcare, Mindray, which collectively held a market share of 82.0% in 2025.

The pediatric imaging market is being reshaped by the clinical need for repeat diagnostic assessment across childhood oncology, neurology, congenital disease, trauma, and developmental care. AI-enabled reconstruction, faster acquisition protocols, and portable systems are widening the settings in which pediatric imaging can be delivered while increasing the value of installed clinical infrastructure.

GMI Analyst View

Based on input from industry experts. The global pediatric imaging market reached USD 9.40 billion in 2024, reflecting convergent demand from pediatric oncology and neurology imaging upgrades alongside equipment procurement across expanding hospital networks. This benchmark indicates that clinical workflow modernization and infrastructure investment were reinforcing demand before the current base year.

Pediatric Imaging Market Trends, Growth Drivers & GMI Forecast Outlook

Clinical imaging demand is broadening beyond tertiary pediatric hospitals as technology reduces acquisition time, sedation dependence, and operating complexity. The forecast remains conditioned by the pace at which providers can fund advanced platforms, establish pediatric validation pathways, and extend specialist capability into lower-resource care settings.

Key Drivers

Driver Evidence signal Market-demand implication GMI forecast condition
Rising global childhood cancer incidence IARC reported that more than 275,000 children and adolescents aged 0-19 were diagnosed with cancer worldwide in 2024; leukaemia, CNS tumours, and lymphomas were among the leading types [1] Sustained demand for oncology-directed PET-CT, advanced MRI, and photon-counting CT across pediatric cancer centers Oncology applications sustain a CAGR premium above the overall market average through 2035, led by North America and Asia Pacific procedure-volume growth
Congenital heart disease imaging burden Approximately 1.35 million children are born with CHD annually, requiring serial echocardiography, cardiac MRI, and cardiac CT across the patient lifecycle [2] Sustained demand for fetal and postnatal cardiac imaging as CMR protocol adoption expands with institutional capacity Cardiology imaging maintains solid growth as CHD prevalence and imaging-protocol adoption spread across lower-middle-income regions
AI-enabled scan-time reduction and sedation-free protocols Photon-counting CT and AI-powered reconstruction enable rapid pediatric acquisition with reduced motion artefact; protocol-optimized systems can reduce routine sedation dependence Modality upgrade cycles shorten, while point-of-care portable ultrasound demand grows in tier-2 pediatric facilities AI-integrated portfolio penetration accelerates across MRI and CT segments through the forecast period

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Childhood cancer creates a recurring imaging requirement rather than a one-time diagnostic event. Leukemia, central nervous system tumors, and lymphomas can require staging, treatment-response assessment, complication management, and longitudinal surveillance, sustaining use of high-resolution cross-sectional imaging across the care continuum [1]. As oncology capacity develops in emerging healthcare systems, providers are incorporating these repeat imaging pathways into pediatric cancer services.

Congenital heart disease creates demand from prenatal screening through long-term follow-up. Echocardiography remains foundational, while cardiac MRI and CT become increasingly important when anatomical complexity, surgical planning, or longitudinal functional assessment require more detailed visualization [2]. This serial-care model supports durable utilization where pediatric cardiology infrastructure and specialist interpretation capacity are available.

AI-assisted reconstruction and faster acquisition protocols can alter the economic case for pediatric imaging by increasing throughput and reducing dependency on anesthesia-supported workflow. For MRI, shorter examinations can improve access for younger children; for CT, dose-efficient acquisition supports use in time-critical or anatomically complex indications. These advances also increase the commercial relevance of platform upgrades rather than simple equipment replacement.

Key Restraints

Restraint Evidence signal Market-demand implication GMI forecast condition
Ionising radiation exposure risk in children U.S. FDA guidance indicates that approximately one-third of children who have undergone CT scans have had at least three scans, reinforcing ALARA-based dose management [3] Radiation-sensitive populations favor MRI and ultrasound where clinically appropriate, moderating CT expansion CT segment growth remains below the overall market average through 2035 as MRI and ultrasound gain procedural share
Equipment cost and access barriers in lower-income settings Only 54% of CHD surgery centers in middle-income countries reported access to cardiac MRI [4] Premium MRI and advanced CT remain inaccessible to many pediatric hospitals beyond top-tier urban facilities APAC and MEA uptake remains concentrated in tier-1 hospitals, with broader penetration dependent on low-field and portable systems
Regulatory and clinical-validation requirements specific to pediatric imaging Pediatric imaging devices require age-stratified validation, pediatric conformity assessment, and testing across neonatal, infant, and adolescent use conditions Longer development cycles and higher validation costs reinforce established OEM positioning Regulatory depth and pediatric evidence portfolios sustain concentration among established OEMs through 2035

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Radiation sensitivity remains a defining clinical constraint in pediatric CT and fluoroscopy. Children have developing tissues and longer expected lifespans over which radiation-related risk may manifest, leading providers to apply the ALARA principle and favor radiation-sparing alternatives when diagnostic requirements permit [3]. The result is not the displacement of CT in acute or complex care, but more selective use and continued pressure for dose-efficient systems.

Access constraints are especially pronounced for advanced cross-sectional imaging. The gap in cardiac MRI availability at congenital heart disease surgery centers illustrates the capital, technical, and staffing barriers that can persist even within specialized facilities [4]. Low-field MRI, portable ultrasound, and service models that improve remote interpretation offer potential routes to widen access, but they do not eliminate procurement or workforce limitations.

Pediatric-specific validation requirements also raise the threshold for product commercialization. Manufacturers must demonstrate performance across a broad developmental range with distinct anatomy, dose requirements, physiology, and workflow conditions. This favors suppliers with established pediatric clinical evidence, regulatory capabilities, and installed customer relationships.

GMI Analyst View

We see the forecast as a contest between clinical necessity and system capacity. Demand is durable because imaging is embedded in diagnosis, treatment planning, and follow-up; however, its conversion into revenue depends on capital budgets, pediatric-specialist availability, and the ability of providers to deploy lower-complexity platforms beyond major referral centers.

Pediatric Imaging Market Segment Analysis

By Imaging Modality

The pediatric imaging market's MRI segment generated USD 3.42 billion in 2025 and is projected to expand at an 8.5% CAGR from 2026 to 2035. MRI benefits from its radiation-free profile and its suitability for neurologic, oncologic, and musculoskeletal assessment. Faster sequences and AI reconstruction are improving workflow feasibility for younger patients, while low-field and open-bore configurations can extend access beyond traditional hospital radiology departments.

Pediatric Imaging Market Size, by Modality, 2025 & 2035 (USD Billion)
Pediatric Imaging Market Size, by Modality, 2025 & 2035 (USD Billion)

Ultrasound is projected to reach USD 5.55 billion by 2035 and accounted for 28.0% of the market in 2025. Its bedside deployability, low operating burden, and absence of ionizing radiation make it central to neonatal, cardiac, abdominal, and emergency care. Handheld and portable systems are particularly relevant where providers need immediate diagnostic capability without the infrastructure required for MRI or CT.

CT represented 22.0% of the pediatric imaging market in 2025 and is projected to reach USD 4.28 billion by 2035. The modality remains essential in trauma, thoracic assessment, complex anatomy, and urgent oncology or cardiology workflows. Its strategic position increasingly depends on dose reduction, rapid acquisition, and high-resolution technology that can address the clinical concerns associated with pediatric radiation exposure.

X-ray is projected to reach USD 1.90 billion by 2035 and held an 11.0% market share in 2025. It remains the high-frequency entry point for fracture assessment, chest imaging, bone-age analysis, and scoliosis screening. Digital workflow integration and AI-supported interpretation can preserve its value in high-volume settings despite the mature nature of the modality.

Other modalities are projected to reach USD 1.01 billion by 2035 and represented 5.0% of the market in 2025. Nuclear medicine, PET-CT, and fluoroscopy serve specialized clinical needs, particularly in oncology, interventional procedures, and complex functional assessment. Their growth opportunity is closely linked to the expansion of specialized pediatric service lines and molecular imaging capabilities.

By Application

Orthopedics generated USD 3.12 billion in 2025 and is projected to grow at a 6.5% CAGR from 2026 to 2035. High procedure frequency across fractures, sports injuries, scoliosis, and developmental conditions supports a stable demand base. The application also uses complementary modalities, with x-ray often serving as an initial diagnostic tool and MRI supporting detailed evaluation of soft tissue, cartilage, and growth plates.

Neurology is projected to reach USD 4.77 billion by 2035 and represented 22.0% of the pediatric imaging market in 2025. Brain tumor assessment, epilepsy investigation, neurodevelopmental evaluation, and complex neurological follow-up make MRI-led imaging central to this segment. Motion-robust protocols and accelerated acquisition are especially consequential because they can improve examination completion without deepening reliance on sedation resources.

Cardiology generated USD 1.71 billion in 2025 and is projected to reach USD 3.52 billion by 2035. Pediatric cardiac imaging spans fetal assessment, postnatal echocardiography, cardiac MRI, and CT for surgical planning or complex follow-up. The serial nature of congenital heart disease management makes imaging utilization less dependent on episodic demand than many routine diagnostic applications [2].

Oncology is projected to reach USD 3.19 billion by 2035 and is expected to advance at an 8.5% CAGR from 2026 to 2035. Imaging is embedded in tumor staging, response assessment, surveillance, and management of treatment-related complications. As cancer centers expand pediatric capability, the application supports demand for MRI, PET-CT, and advanced CT workflows that can balance diagnostic precision with child-specific safety requirements [1].

Gastroenterology held a 10.0% market share in 2025 and is projected to reach USD 1.96 billion by 2035. Abdominal ultrasound, MRI enterography, and targeted cross-sectional imaging support evaluation of liver conditions, inflammatory bowel disease, and acute abdominal symptoms. The segment's diagnostic pathway increasingly favors radiation-sparing modalities in non-emergent care settings.

Other applications generated USD 600 million in 2025 and are projected to reach USD 1.07 billion by 2035. Pulmonology, urology, general diagnostics, and emergency imaging create a broad baseline of demand across care settings. This category benefits from the growing availability of portable imaging and remote interpretation models that can support facilities with limited subspecialty coverage.

By End Use

Hospitals are projected to generate USD 10.20 billion by 2035 and accounted for 52.0% of market revenue in 2025. Children's hospitals and academic medical centers remain the primary sites for high-acuity MRI, CT, nuclear medicine, and interventional imaging. Their purchasing decisions increasingly emphasize interoperable platforms, pediatric protocol libraries, and productivity improvements that can relieve staffing and capacity pressure.

Pediatric Imaging Market Share, by End Use, 2025
Pediatric Imaging Market Share, by End Use, 2025

Diagnostic centers generated USD 2.82 billion in 2025 and are projected to reach USD 5.80 billion by 2035. Outpatient migration is expanding as MRI and CT become more available beyond hospital campuses, particularly in private imaging networks. Teleradiology and AI-supported workflow tools can increase the viability of centers in secondary cities, though specialist pediatric interpretation remains a critical service differentiator.

Pediatric clinics held a 12.0% market share in 2025 and are projected to grow at an 8.0% CAGR from 2026 to 2035. The setting is gaining importance as portable ultrasound, point-of-care systems, and emerging low-field MRI options bring diagnostic capability closer to routine specialty care. Clinics can use these tools to shorten referral pathways for chronic neurologic, cardiac, abdominal, and musculoskeletal conditions.

Other end-use settings generated USD 800 million in 2025 and are projected to reach USD 1.61 billion by 2035. Research institutions, teleradiology providers, and developing remote-care models serve specialized but expanding roles. Their contribution is strengthened by clinical trial imaging, technology validation, and the need to extend pediatric interpretation capacity across dispersed scanner networks.

GMI Analyst View

We believe segment performance will increasingly reflect whether imaging can be integrated into continuous pediatric care rather than delivered as an isolated radiology event. Radiation-sparing modalities, portable platforms, and workflow software are expanding the commercial importance of settings that can diagnose, monitor, and escalate care without transferring every patient to a tertiary imaging department.

Pediatric Imaging Market Regional Analysis

Pediatric Imaging Market Share, by Region, 2025 & 2035
Pediatric Imaging Market Share, by Region, 2025 & 2035

North America Pediatric Imaging Market Analysis

The pediatric imaging market in North America generated USD 4.09 billion in 2025 and is projected to reach USD 7.65 billion by 2035. Regional demand is led by replacement cycles, advanced pediatric referral networks, and investment in AI-integrated MRI and CT systems. The market's scale reflects both high procedure intensity and the concentration of hospitals able to support complex imaging, anesthesia, subspecialist interpretation, and longitudinal follow-up.

United States

The United States generated USD 3.57 billion in 2025 and is projected to reach USD 6.63 billion by 2035. Dedicated children's hospitals, academic radiology programs, and expanding point-of-care imaging use support demand across oncology, neurology, emergency, and cardiology pathways. Investment is increasingly directed toward workflow-enhancing systems that reduce scan times and improve patient experience.

Canada

Canada generated USD 520 million in 2025 and is projected to reach USD 930 million by 2035. Publicly funded imaging services and pediatric specialty centers support steady demand, while low-dose protocols and structured procurement programs reinforce technology modernization. Capacity remains concentrated in major urban academic institutions, increasing the value of coordinated referral and remote-reading pathways.

Europe Pediatric Imaging Market Analysis

Europe held a 25.2% share of the pediatric imaging market in 2025 and is projected to advance at a 6.3% CAGR from 2026 to 2035. Established public health systems create a replacement-led market characterized by protocol modernization, pediatric AI research, and uneven infrastructure development across Western, Northern, Central, and Eastern Europe.

Germany

Germany generated USD 310 million in 2025 and is projected to reach USD 550 million by 2035. University hospitals, domestic imaging technology expertise, and replacement demand for MRI and CT systems underpin growth. Investment is focused on improving diagnostic performance and workflow quality within mature tertiary-care networks.

United Kingdom

The United Kingdom generated USD 280 million in 2025 and is projected to reach USD 500 million by 2035. Digital imaging modernization across the National Health Service supports adoption of AI-enabled workflow tools and upgraded systems at pediatric hospital trusts. Demand is closely tied to the ability of providers to integrate imaging data across regional referral networks.

France

France generated USD 230 million in 2025 and is projected to expand at a 6.0% CAGR from 2026 to 2035. Pediatric oncology, neurology, and academic-hospital imaging programs support demand for advanced diagnostic capacity. Replacement investment is shaped by public planning priorities and the need to maintain specialized imaging access across regional care networks.

Italy

Italy generated USD 180 million in 2025 and is projected to reach USD 320 million by 2035. Public healthcare investment and regional pediatric imaging initiatives support procurement activity, particularly where hospital systems are strengthening referral pathways. Demand is concentrated in specialized institutions but can broaden as regional centers improve access to advanced modalities.

Spain

Spain generated USD 140 million in 2025 and is projected to reach USD 240 million by 2035. Regional health authorities and pediatric emergency care settings are increasing the relevance of portable ultrasound and digitally connected radiology workflows. Growth depends on sustaining capital programs while improving access outside major metropolitan centers.

Rest of Europe

Rest of Europe is projected to reach USD 2.63 billion by 2035 and is expected to grow at a 6.5% CAGR from 2026 to 2035. The group includes mature northern markets pursuing AI-enabled subspecialty imaging and developing systems that are expanding equipment access through hospital modernization. This produces a multi-speed regional landscape in which technology adoption and funding capability vary substantially.

Asia Pacific Pediatric Imaging Market Analysis

Asia Pacific is projected to reach USD 5.99 billion by 2035 and is expected to grow at a 9.2% CAGR from 2026 to 2035. The pediatric imaging market in the region is being supported by hospital construction, public health investment, expanding insurance access, and a large pediatric population. Demand increasingly extends beyond capital-city referral hospitals as providers adopt cost-optimized ultrasound, MRI, and digital radiography systems.

China

China generated USD 980 million in 2025 and is projected to reach USD 2.52 billion by 2035. National pediatric healthcare development and hospital-capacity expansion support growth across ultrasound, MRI, and entry-level advanced imaging systems. Domestic suppliers and international OEMs compete as providers seek technologies that can serve both high-volume urban hospitals and developing regional networks.

India

India generated USD 480 million in 2025 and is projected to reach USD 1.34 billion by 2035. Public health coverage initiatives and hospital infrastructure expansion are widening the potential customer base beyond large metropolitan facilities. Affordable portable ultrasound and low-field MRI configurations are commercially important because they can align with capital constraints in tier-2 and tier-3 healthcare settings.

Japan

Japan generated USD 420 million in 2025 and is projected to grow at a 7.5% CAGR from 2026 to 2035. An aging installed base and a technologically sophisticated provider environment support demand for MRI and CT modernization. Local manufacturer strength and high expectations for image quality position replacement decisions around performance, workflow, and service continuity.

South Korea

South Korea generated USD 170 million in 2025 and is projected to reach USD 370 million by 2035. Advanced ultrasound, digital workflow capability, and national insurance coverage support adoption across pediatric cardiology and abdominal imaging. The market benefits from a technology-forward provider base and local supplier participation in AI-enhanced imaging platforms.

Australia

Australia generated USD 120 million in 2025 and is projected to reach USD 240 million by 2035. Public reimbursement and remote-care requirements support imaging demand across dispersed populations. Connectivity, portable platforms, and coordinated specialist interpretation are important to extending pediatric imaging access beyond major urban hospitals.

Rest of Asia Pacific

Rest of Asia Pacific is projected to reach USD 780 million by 2035 and is expected to advance at a 9.0% CAGR from 2026 to 2035. Hospital development in Southeast Asian economies is creating new demand for advanced pediatric diagnostics, while regional hubs support training and technology diffusion. The pace of expansion will vary according to health-system financing, procurement execution, and specialist workforce availability.

Latin America Pediatric Imaging Market Analysis

The pediatric imaging market in Latin America generated USD 590 million in 2025 and is projected to reach USD 1.16 billion by 2035. Growth is supported by private hospital investment, selective public-sector modernization, and gradual expansion of formal healthcare access. Providers face a balancing challenge between demand for advanced cross-sectional imaging and the capital limitations that favor portable or lower-cost platforms.

Brazil

Brazil generated USD 350 million in 2025 and is projected to reach USD 720 million by 2035. Public imaging investment and private hospital-group procurement support demand for MRI, CT, and ultrasound. The market combines large clinical need with uneven infrastructure, making differentiated equipment portfolios important across public and private care settings.

Mexico

Mexico generated USD 150 million in 2025 and is projected to reach USD 280 million by 2035. Healthcare infrastructure expansion and private-sector investment in major cities support demand for pediatric imaging capacity. Procurement opportunities are strongest where providers can pair system installation with training, maintenance, and workflow support.

Argentina

Argentina generated USD 40 million in 2025 and is projected to reach USD 70 million by 2035. Demand is concentrated in private healthcare and major urban centers, while capital-equipment purchasing remains sensitive to macroeconomic volatility. Suppliers with flexible commercial models and durable local service coverage are better positioned to address this environment.

Rest of Latin America

Rest of Latin America generated USD 50 million in 2025 and is projected to reach USD 90 million by 2035. Healthcare reform, hospital expansion, and specialty-service development are increasing the need for pediatric diagnostic infrastructure. Growth is likely to remain selective, with major urban systems leading adoption before smaller facilities gain advanced imaging capacity.

Middle East & Africa Pediatric Imaging Market Analysis

Middle East & Africa held a 3.5% share of the pediatric imaging market in 2025 and is projected to reach USD 810 million by 2035. Demand is driven by Gulf healthcare investment, referral-hospital development, and the early expansion of portable imaging in underserved markets. The region's outlook is especially sensitive to public capital allocation, funding continuity, and the ability to train specialist pediatric imaging teams.

Saudi Arabia

Saudi Arabia is projected to reach USD 240 million by 2035 and is expected to grow at a 9.0% CAGR from 2026 to 2035. National healthcare transformation programs and investments in tertiary pediatric facilities support demand for MRI, CT, and specialized imaging services. The opportunity is concentrated in systems that can combine equipment acquisition with clinical protocol development and workforce expansion.

United Arab Emirates

The United Arab Emirates generated USD 70 million in 2025 and is projected to reach USD 180 million by 2035. Advanced referral care, government investment, and the country's role as a destination for complex pediatric cases support premium imaging demand. Providers are likely to prioritize interoperable systems and patient-centered workflow improvements.

South Africa

South Africa generated USD 60 million in 2025 and is projected to reach USD 120 million by 2035. Tertiary children's hospitals and private imaging networks sustain specialized demand, while public-sector expansion could broaden access over time. Funding constraints and uneven geographic distribution remain material limitations on more widespread adoption.

Rest of Middle East & Africa

Rest of Middle East & Africa generated USD 120 million in 2025 and is projected to expand at an 8.0% CAGR from 2026 to 2035. Gulf procurement programs provide a relatively stable demand base, while African markets are developing pediatric imaging capacity through portable technologies and externally supported infrastructure programs. The commercial opportunity depends heavily on affordability, service coverage, and durable clinical training models.

GMI Analyst View

We expect regional differentiation to remain the market's central strategic feature. Mature systems create value through advanced replacement and workflow upgrades, whereas emerging markets depend on new capacity formation and affordable technology deployment. Suppliers that can match modality sophistication to local operating conditions will be better positioned than those relying on a uniform premium-equipment model.

Pediatric Imaging Market Share & Competitive Landscape

The pediatric imaging market share landscape is concentrated among established original equipment manufacturers with broad installed bases, pediatric evidence portfolios, regulatory capabilities, and multimodality product coverage. Competition centers on dose optimization, faster acquisition, AI-enabled workflow, pediatric-specific usability, service networks, and the capacity to support customers across complex hospital and lower-acuity settings.

Siemens Healthineers held a 26.5% share of the pediatric imaging market in 2025. Its MRI and CT position is supported by photon-counting CT, low-field MRI, and workflow tools designed to improve speed and reduce sedation dependence. Its clinical evidence base and ability to support high-acuity children's hospitals reinforce competitive strength in technically demanding imaging pathways.

GE HealthCare accounted for 21.8% of pediatric imaging market share in 2025. The company has particular relevance in ultrasound and x-ray environments, as well as MRI platforms used in pediatric academic centers. Its collaboration with Cincinnati Children's demonstrates an effort to develop pediatric-specific innovations across MRI, ultrasound, molecular imaging, and CT [5].

Koninklijke Philips held a 14.2% share of the pediatric imaging market in 2025. Its competitive position spans ultrasound, MRI, patient monitoring, and clinical informatics, giving it relevance for health systems pursuing integrated care pathways. The company's proposition is strongest where purchasers value equipment interoperability and workflow standardization across diagnostic and patient-management functions.

Canon Medical Systems competes through CT innovation, including deep-learning reconstruction and low-dose imaging capability relevant to pediatric care. Its domestic foundation in Japan and expanding Asia Pacific footprint provide a platform for broader participation in advanced CT categories, particularly where providers are seeking to improve diagnostic quality without increasing dose burden.

FUJIFILM Healthcare is positioned in digital x-ray, ultrasound, radiology IT, and image-management workflows. Its ability to combine imaging platforms with information technology supports customers seeking integrated diagnostic operations, particularly in settings where digital radiography remains a high-volume component of pediatric care.

Mindray is strengthening its role through cost-competitive ultrasound and growing participation in imaging systems across China and other emerging markets. Its commercial position is especially relevant where providers require accessible technology, local distribution, and practical configurations that can serve facilities unable to procure premium advanced-modality platforms.

Agfa-Gevaert Group and Carestream Health compete in digital radiography and radiology information workflows, while Shimadzu retains regional strength in x-ray systems. Esaote serves specialized musculoskeletal applications, Samsung Healthcare is expanding AI-enhanced ultrasound participation, and emerging companies such as Hyperfine, Analogic, and LMT Medical Systems address portable or specialized imaging opportunities.

Recent Industry Developments

GE HealthCare and Cincinnati Children's establish pediatric imaging innovation hub. In April 2025, GE HealthCare and Cincinnati Children's announced a collaborative research program focused on pediatric imaging innovation across MRI, ultrasound, molecular imaging, and CT. The initiative includes work on child-sized MR coils, motion-robust MRI techniques, AI-enabled liver ultrasound, and optimized CT workflows [5].

Hyperfine receives FDA clearance for next-generation portable MRI system. In June 2025, Hyperfine announced FDA clearance for its Swoop® Portable MR Imaging® V2 System, powered by Optive AI software. The platform is cleared for brain imaging in patients of all ages and is intended for settings where conventional MRI infrastructure is impractical [6].

AZmed receives FDA clearance for pediatric fracture detection AI. In September 2024, AZmed announced FDA 510(k) clearance for Rayvolve, an AI solution for fracture detection on pediatric x-rays. The development reflects continued commercialization of pediatric-specific AI tools designed to support radiology workflow and diagnostic review in high-volume imaging settings [7].

Need a specific section of this report?

Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.

Authors:  Monali Tayade, Sampada Kulkarni

Frequently Asked Questions (FAQs):

The pediatric imaging market size was estimated at USD 10.06 billion in 2025 and is expected to reach USD 10.76 billion in 2026.
The market is projected to reach USD 20.12 billion by 2035, growing at a CAGR of 7.2% from 2026 to 2035.
North America currently holds the largest share of the pediatric imaging market in 2025.
Asia Pacific is projected to be the fastest-growing region during the forecast period.
Some of the major players in pediatric imaging market include Siemens Healthineers, GE HealthCare, Koninklijke Philips, Canon Medical Systems, FUJIFILM Healthcare, Mindray.

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 20+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Industry journals, trade publications, and specialized media.

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 20+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Authors:  Monali Tayade, Sampada Kulkarni
We use cookies to enhance user experience. (Privacy Policy)